Acquisition Synergy Leverage HORIBA's expanded laboratory Chemistry and Immunochemistry capabilities from the MedTest Dx and Pointe Scientific acquisition to cross-sell integrated IVD solutions to existing customers seeking a broader test menu and streamlined supplier relationships.

Clinical Fit Target small to mid-sized labs with FDA 510K and CLIA clearance expertise as a differentiator, offering end-to-end compliance-enabled chemistry solutions that reduce regulatory friction and speed time to market for new tests.

Technology Leverage Promote the combined tech stack and manufacturing capabilities to differentiate through validated R&D pipelines, robust QA, and scalable production for new IVD assays, appealing to labs prioritizing reliability and standardization.

Strategic Partnerships Capitalize on recent collaborations and channel breadth by proposing co-developed solutions with HORIBA Medical, tapping into established distribution channels and partner ecosystems to reach larger lab networks.

Growth Markets Position offerings toward expanding market segments such as diabetes testing and inline Raman/biopharma monitoring evidenced by recent partnerships, signaling a push into high-growth, data-rich diagnostic workflows.